Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer

Biomarker Study for Personalized Anti-cancer Therapy in Gastrointestinal Cancer - Biomarker Study in Gastrointestinal Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004069

Enrollment

400

Registered

2010-10-01

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Biliary Tract Cancer,

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, and biliary tract cancer 2) Receiving cancer chemotherapy 3) No prior treatment with anti-cancer agents and radiation 4) Adequate organ function 5) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Chemoradiation except for esophageal cancer treatment 2) Active infectious disease 3) Ileus 4) Severe diarrhea 5) Interstitial pneumonia 6) Severe diabetes 7) Under treatment for unstable angina or myocardial infarction 8) Metastasis to central nervus system 9) Massive ascites or pleural effusion 10) Dementia 11) Other inappropriate cases according to primary doctor's evaluation

Design outcomes

Primary

Measure	Time frame
Identification and clinical application of predictors of tumor response and adverse events in GI cancer chemotherapy	—

Countries

Japan

Contacts

Public ContactJunichi Matsubara

Kyoto University Hospital Department of Gastroenterology and Hepatology

jmatsuba@kuhp.kyoto-u.ac.jp075-751-3518

Outcome results